Sign In

Christina Trojel-Hansen

Entrepreneur in Residence at ARCH Venture Partners - Biotech Founder and CEO - Investor - Building newcos within Life Sciences

Christina Trojel-Hansen is a highly passionate individual with a strong focus on innovation in the (bio)technology and life sciences sectors.

She has a solid background in life sciences coupled with expertise in new business development, intellectual property rights (IPR), and venture creation.

Christina has been recognized for her achievements, being selected as one of the Top 10 inspirational women in Nordic Life Science in 2023 and listed in the Endpoints 20 under 40 in 2021.

In 2017, she was chosen as one of the Berlingske Business Talent100, which highlights emerging talents with the potential to lead in the future.

Christina has played a key role in identifying and developing successful academic projects, leading to significant Series A investments in companies like Adcendo and Stipe.

She has co-founded multiple NewCos and is known for her entrepreneurial spirit, being involved in various capacities from founder and CEO to investor within the life sciences domain.

With a strong educational background including a Master's degree in Nanobiotechnology, an Industrial PhD in Drug Discovery, and a Certificate in Entrepreneurial Leadership, Christina brings a wealth of knowledge to her endeavors.

Her professional journey includes roles such as Entrepreneur in Residence at ARCH Venture Partners, Co-Founder at Comorin and CNS2, and CEO at Tune Therapeutics and Oscine Therapeutics.

She has also contributed to organizations like BioInnovation Institute, Novozymes, and University of Rochester Medical Center in advisory, mentoring, and executive positions.

Christina Trojel-Hansen's diverse experience spans from academia to industry, with a focus on driving innovation, business growth, and leadership development in the life sciences sector.

Christina Trojel-Hansen
Add to my network

Location

Boston, Massachusetts, United States